Cargando…

PB2092: INCIDENCE AND RISK FACTORS ASSOCIATED WITH BLEEDING FOLLOWING ANTI-B CELL MATURATION ANTIGEN CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

Detalles Bibliográficos
Autores principales:	Mohammed, Turab, Shahzad, Moazzam, Peres, Lauren, Khadka, Sushmita, Colinleitzinger, Christelle, Babu, Abida, Doyle, William, Puglianini, Omar Castaneda, Oswald, Laura, De Avila, Gabe, Grajales-Cruz, Ariel, Blue, Brandon, Ochoa-Bayona, Jose, Smith, Eric, Corallo, Salvatore, Khimani4, Farhad, Faramand, Rawan, Elmariah, Hany, Lazaryan, Aleksandr, Jain, Michael, Liu, Hien, Nishihori, Taiga, Shain, Ken, Baz, Rachid, Alsina, Melissa, Locke, Frederick, Freeman, Ciara, Hansen, Doris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Publication Only
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429647/ http://dx.doi.org/10.1097/01.HS9.0000975160.46377.e2

Ejemplares similares

Cardiac events after standard of care idecabtagene vicleucel for relapsed and refractory multiple myeloma
por: Lee, Dae Hyun, et al.
Publicado: (2023)

Cardiac and inflammatory biomarker differences in adverse cardiac events after chimeric antigen receptor T-Cell therapy: an exploratory study
por: Lee, Dae Hyun, et al.
Publicado: (2023)

Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience
por: Ionescu, Filip, et al.
Publicado: (2022)

Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma
por: Logue, Jennifer M., et al.
Publicado: (2022)

A phase 2 multicenter trial of ofatumumab and prednisone as initial therapy for chronic graft-versus-host disease
por: Lazaryan, Aleksandr, et al.
Publicado: (2022)

P1540: COVID-19 INFECTION AMONG CAR-T CELL THERAPY RECIPIENTS: A SINGLE CENTER EXPERIENCE
por: Din, Mohammad Ammad Ud, et al.
Publicado: (2023)

Insights on Genomic and Molecular Alterations in Multiple Myeloma and Their Incorporation towards Risk-Adapted Treatment Strategy: Concise Clinical Review
por: Nishihori, Taiga, et al.
Publicado: (2017)

Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience
por: Ionescu, Filip, et al.
Publicado: (2023)

Reconfiguration hardware pour transformer le module CAMAC 3CI-2092 dans le module-3IDI 2092
por: Perriollat, F
Publicado: (1983)

Minimal Residual Disease Assessment in the Context of Multiple Myeloma Treatment
por: Nishihori, Taiga, et al.
Publicado: (2016)

2092. Acceptability and Effectiveness of Implementation Strategies on Fluoroquinolone (FQ) Prescribing
por: Suda, Katie J, et al.
Publicado: (2019)

Patient-Reported Outcomes among Multiple Myeloma Patients Treated with Standard of Care Idecabtagene Vicleucel
por: Oswald, Laura B., et al.
Publicado: (2023)

Manuel d'utilisation du Module CAMAC 3IDI 2092
por: Perriollat, F
Publicado: (1983)

The Rule of Law Conditionality Under Regulation No 2092/2020—Is it all About the Money?
por: Łacny, Justyna
Publicado: (2021)

2092 A multicenter study of fecal microbiota transplantation for Clostridium difficile infection in children
por: Nicholson, Maribeth R., et al.
Publicado: (2018)

P1318: THE IMPACT OF MELPHALAN DOSING IN COMBINATION WITH FLUDARABINE IN CLINICAL OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES RECEIVING ALLO-HCT
por: Albanyan, O., et al.
Publicado: (2022)

691. Activity of TNP-2092 Against Biofilms Formed by Prosthetic Joint Infection-Associated Staphylococci
por: Fisher, Cody, et al.
Publicado: (2019)

Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients
por: Yang, Heera, et al.
Publicado: (2022)

Rhinitis, sinusitis and ocular disease – 2092. The MSNOT-20 questionnaire: repeatability and disease analysis of rhinitis/rhinosinusitis
por: Sami, Amtul Salam, et al.
Publicado: (2013)

PB2092: PRIMARY BONE DIFFUSE LARGE B CELL LYMPHOMA: A SINGLE CENTER EXPERIENCE
por: Abichou, G., et al.
Publicado: (2022)

Primary progression during frontline CIT associates with decreased efficacy of subsequent CD19 CAR T-cell therapy in LBCL
por: Perez, Ariel, et al.
Publicado: (2022)

Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma
por: Logue, Jennifer M., et al.
Publicado: (2020)

Case of Myocarditis After Chimeric Antigen Receptor T Cells With Intracardiac Lymphoma
por: Lee, Dae Hyun, et al.
Publicado: (2022)

IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation
por: Betts, Brian C., et al.
Publicado: (2017)

2092: Chronic branched-chain amino acid ingestion aggravates hilar neuron loss in a rodent model of temporal lobe epilepsy
por: Evan Gruenbaum, Shaun, et al.
Publicado: (2018)

Characterization of Cancer/Testis Antigens as Prognostic Markers of Ovarian Cancer
por: Vlasenkova, Ramilia, et al.
Publicado: (2023)

Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myeloma
por: Peres, Lauren C., et al.
Publicado: (2022)

Abstract No.: ABS2092: Study of perioperative modified early obstetric warning scores among pregnancy Induced hypertensive patients posted for caesarean deliveries.
por: Thomas, Mareena
Publicado: (2022)

Dual Functionalized Lactococcus lactis Shows Tumor Antigen Targeting and Cytokine Binding in Vitro
por: Zahirović, Abida, et al.
Publicado: (2022)

2092. How Long Should You Delay Insertion of a Long-Term Central Venous Catheter (LTCVC) in Patients with Candida Bloodstream Infection (CBSI)?
por: Kagan, Evgenia, et al.
Publicado: (2018)

Treatment Response in Enteric Fever in an Era of Increasing Antimicrobial Resistance: An Individual Patient Data Analysis of 2092 Participants Enrolled into 4 Randomized, Controlled Trials in Nepal
por: Thompson, Corinne N., et al.
Publicado: (2017)

A Critical Appraisal of Extracorporeal Photopheresis as a Treatment Modality for Acute and Chronic Graft-Versus-Host Disease
por: Rafei, Hind, et al.
Publicado: (2017)

The relationship between antigen concentration, antigen internalization, and antigenic complexes: modeling insights into antigen processing and presentation
Publicado: (1990)

Discriminating antigen and non-antigen using proteome dissimilarity: bacterial antigens
por: Ramakrishnan, Kamna, et al.
Publicado: (2010)

PReS-FINAL-2092: Bone marrow cells (BMC) added to platelet-rich plasma (PRP) for treatment of bone degenerative processes in JIA patients: follow-up of 2 cases
por: Salvati, P, et al.
Publicado: (2013)

Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients (Endocrinol Metab 2022;37:652-63, Heera Yang et al.)
por: Park, Hyunju, et al.
Publicado: (2022)

Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients (Endocrinol Metab 2022;37:652-63, Heera Yang et al.)
por: Kim, Sue Youn, et al.
Publicado: (2022)

von Willebrand factor antigen levels are associated with burden of rare nonsynonymous variants in the VWF gene
por: Sadler, Brooke, et al.
Publicado: (2021)

Acute patient‐reported outcomes in B‐cell malignancies treated with axicabtagene ciloleucel
por: Hoogland, Aasha I., et al.
Publicado: (2021)

AntigenDB: an immunoinformatics database of pathogen antigens
por: Ansari, Hifzur Rahman, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_29l37tfvhln9esk638fhm2ss3d